Corvus Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $71.1M
Liabilities Breakdown FY2025
Total Liabilities: $9.9M
Asset Breakdown
Total Assets: $71.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.6M | 6.4% |
| Accounts Receivable | $37.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $220.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $66.3M | 93.2% |
Liabilities Breakdown
Total Liabilities: $9.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 25.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.4M | 74.9% |